Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
83.50    6.00 (7.74%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £11.17m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Trading Statement

Today 07:00

RNS Number : 0392K
Arcontech Group PLC
29 June 2026
Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

ARCONTECH GROUP PLCΒ 

("Arcontech" or the "Company")

Client Win/Trading update

Arcontech (AIM: ARC), the provider of software products and services for the management of real-time financial market-data, is pleased to announce that it has secured a new contract for its CityVision real-time market data platform to enable multiple data sources to be consumed by various applications written in different programming languages.

Following a successful bidding process, Arcontech has signed a 3-year contract with a total value of approximately Β£800k with a major European bank for deployment of its software in various areas within its trading infrastructure. The contract is with a new customer and has strong expansion potential across the customer's wider market-data estate, with revenue recognition expected to commence in calendar Q3 2026.

As a vendor agnostic market data platform, Arcontech CityVision provides a cost-effective alternative to existing platforms and the flexibility to choose any source of data to avoid "vendor lock-in". Arcontech CityVision is relied upon by some of the largest global banks.

The Company would also like to advise that current performance for the full year ended 30 June 2026 for both revenue and profit is in line with market expectations.

Financial expectations noted above are preliminary and are subject to year-end and financial close and audit review processes.

Enquiries:

Arcontech Group plc 020 7256 2300

Geoff Wicks, Chairman and Non-Executive Director

Matthew Jeffs, Chief Executive

Cavendish Capital Markets Ltd (Nomad & Broker) 020 7220 0500

Jonny Franklin Adams/Isaac Hooper (Corporate Finance)

Harriet Ward (Corporate Broking)

To access more information on the Group please visit: www.arcontech.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBLGDLSXDDGLL
Date   Source Headline
29th Jun 20267:00 amRNSTrading Statement
6th Feb 20263:02 pmRNSDirector/PDMR Shareholding
5th Feb 20265:35 pmRNSDirector/PDMR Shareholding
5th Feb 20263:08 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSInterim Results for the Six Months Ended 31 Dec 25
18th Dec 20251:42 pmRNSGrant of Options
18th Dec 20251:42 pmRNSGrant of Options
23rd Sep 20255:53 pmRNSPosting of Annual Report & Notice of AGM
10th Sep 20257:00 amRNSFinal Results for the year ended 30 June 2025
12th Aug 20257:00 amRNSTrading Update
14th Mar 20257:00 amRNS-RArcontech achieves ISO certifications
5th Mar 20254:26 pmRNSDirector/PDMR Shareholding
3rd Mar 20259:26 amPRNNet Asset Value(s)
26th Feb 20254:44 pmRNSDirector/PDMR Shareholding
26th Feb 20251:03 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSInterim Results
5th Dec 20245:45 pmRNSGrant of Options
11th Nov 20247:00 amRNSDirector/PDMR Shareholding
9th Oct 20243:53 pmRNSResult of AGM
17th Sep 20244:46 pmRNSPosting of Annual Report & Notice of AGM
2nd Sep 20247:00 amRNSFinal Results
22nd Jul 20247:00 amRNSTrading Update & Notice of Results
21st Feb 20247:00 amRNSInterim Results
27th Oct 20237:00 amRNSNew Client Win
25th Oct 20231:42 pmRNSResult of AGM
3rd Oct 20235:40 pmRNSPosting of Annual Report & Notice of AGM
5th Sep 20237:00 amRNSFinal Results
24th Jul 20237:00 amRNSTrading Update and Notice of Results
10th May 20237:00 amRNSAppointment of consultant in Singapore
6th Apr 202311:45 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSDirector Retirement
27th Feb 20237:00 amRNSInterim Results
26th Oct 20223:15 pmRNSBoard Appointment
21st Oct 20227:00 amRNSGrant of Options
17th Oct 20222:41 pmRNSResult of AGM
17th Oct 20222:41 pmRNSResult of AGM
23rd Sep 20224:30 pmRNSPosting of Annual Report & Notice of AGM
12th Sep 20227:00 amRNSFinal Results
30th Aug 20227:00 amRNSNotice of Results
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSInterim Results
17th Jan 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20219:06 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSTrading Update
15th Oct 20215:32 pmRNSDirector/PDMR Shareholding
12th Oct 20215:00 pmRNSGrant of Options
11th Oct 20217:00 amRNSHolding(s) in Company
1st Oct 20213:30 pmRNSResult of AGM
8th Sep 20217:00 amRNSPosting of Annual Report & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.